Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Gupta, Ishu
- Analyzing Cognition for COVID-19 Vaccine: A Survey on Undergraduates of Manav Rachna University
Abstract Views :138 |
PDF Views:0
Authors
Anjana Goyal
1,
Reena Doomra
2,
Anushka Choudhary
3,
Anila Maria Varghese
3,
Neha Atkaan
3,
Chirag Kalha
3,
Arjun Singh Verma
3,
Ishu Gupta
3
Affiliations
1 Department of Biochemistry, Manav Rachna Dental College, Faridabad, Haryana, IN
2 Department of Pharmacology, Manav Rachna Dental College, Faridabad, Haryana, IN
3 BDS 3rd Year Students, Manav Rachna Dental College, Faridabad, Haryana, IN
1 Department of Biochemistry, Manav Rachna Dental College, Faridabad, Haryana, IN
2 Department of Pharmacology, Manav Rachna Dental College, Faridabad, Haryana, IN
3 BDS 3rd Year Students, Manav Rachna Dental College, Faridabad, Haryana, IN
Source
IAHRW International Journal of Social Sciences Review, Vol 10, No 2 (2022), Pagination: 147-153Abstract
The following study aims to achieve a clear outline of the perspective of students of Manav Rachna about the vaccination drive being held in the country. Data for Statistical Analysis was chosen to be collected via distributing survey questionnaires, through online platforms. The current study assessed Cognition, Attitude and regarding Fulfilment of government guidelines during vaccination of students of Manav Rachna University, Faridabad towards COVID-19 Vaccine. Results showed a good amount of the population, already vaccinated and the rest manifested a promising attitude towards getting vaccinated in the foreseeable future. After this study It was concluded that the majority of the students had proper knowledge about the vaccine and its possible side effects and all those who were not yet vaccinated are willing to get vaccinated soon. Basically, the survey suggested a optimistic response with regards to Government's drive.Keywords
Attitude, Feedback, Vaccine, COVID-19
References
- Aw, J., Seng, J. J. B., Seah, S. S. Y., & Low, L. L. (2021). COVID-19 vaccine hesitancy: A scoping review of literature in high-income countries. Vaccines, 9(8), 900.
- Bartsch, S. M., O'Shea, K. J., Ferguson, M. C., Bottazzi, M. E., Wedlock, P. T., Strych, U., McKinnell, J. A., Siegmund, S. S., Cox, S.N., Hotez, P. J., & Lee, B. Y. (2020). Vaccine efficacy needed for a COVID-19 Coronavirus vaccine to prevent or stop an epidemic as the sole intervention. American Journal of Preventive Medicine, 59(4), 493-503. https://doi.org/10. 1016/j.amepre.2020.06.011
- Branswell, H. (2021). Comparing three COVID-19 vaccines: Pfizer, moderna, J&J. Stat. Truy cập ngày 28 tháng 2 năm.
- Centers for Disease Control and Prevention CDC (2020). How COVID-19 spreads. [Online] 2020. Cited: June 1, 2020.
- Chakraborty, C., & Agoramoorthy, G. (2020). https://doi.org/10.1016/j.vaccine.202 0.10.056
- Chatterjee, P. (2021). COVID-19: India authorises sputnik V vaccine as cases soar to more than 180000 a day. BMJ (Clinical Research ed.), 373, 978. https://doi.org/10 .1136/bmj.n978
- Chattu, V. K., Pooransingh, S., & Allahverdipour, H. (2021). Global health diplomacy at the intersection of trade and health in the COVID-19 era. Health Promotion Perspectives, 11(1), 1-4. https://doi.org/10.34172/hpp.2021.01
- Goyal, A., Doomra, R., Choudhary, A., Varghese, A. M., Atkaan, N., Jayaswal, A., & Siddiqui, Z. (2020). A comparative study of problems faced by the young-middle aged-/elderly-adults during COVID pandemic in Delhi-NCR (national capital region). Journal of Evolution of Medical and Dental Sciences, 9(43), 3204-3210.
- Goyal, A., Doomra, R.,Thakran, N., Monga, M., Raj, R., & Gupta, S. (2021). India gifted over 55 lakh doses of coronavirus vaccines to several countries: MEA. The Economic Times.
- Javed, S., & Chattu, V. K. (2020). Strengthening the COVID-19 pandemic response, global leadership, and international cooperation through global health diplomacy. Health Promotion Perspectives, 10(4), 300-305. https://doi.org/10.34172/h pp.2020.48
- Khuroo, M. S. (2020). Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: A critical appraisal. International journal of Antimicrobial Agents, 56(3), 106101. https://doi.org/10.1016/j.ija ntimicag.2020.106101
- Kim, J. H., Hotez, P., Batista, C., Ergonul, O., Figueroa, J. P., Gilbert, S., & Bottazzi, M.E. (2021). Correcting COVID-19 vaccine misinformation: Lancet commission on COVID-19 vaccines and therapeutics task force members. The Lancet Global Health.
- Le, T.T., Cramer, J.P., Chen, R., & Mayhew, S. (October 2020). Evolution of the COVID-19 vaccine development landscape. Nature Reviews Drug Discovery, 19(10), 667-668. doi:10.1038/d41573-020-00151-8. PMID 32887942. S2CID 221503034.
- Mascellino, M. T., Di Timoteo, F., De Angelis, M., & Oliva, A. (2021). Overview of the main anti-SARS-CoV2 vaccines: Mechanism of action, efficacy and safety. Infection and Drug Resistance, 14, 3459-3476.
- Owens, B. (2020). Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology. The Lancet Rheumatology, 2(5), e257. https://doi.org/10.1016/S2665-9913(20)30089-8
- Randolph, H. E., & Barreiro, L. B. (2020). Herd immunity: Understanding COVID-19. Immunity, 52(5), 737-741. https://doi.org/10.1016/j.immuni.2020.04.012
- Raoult, D., Hsueh, P. R., Stefani, S., & Rolain, J. M. (2020). Chloroquine for the 2019 novel coronavirus SARS-CoV-2. International Journal of Antimicrobial Agents, 55(3), 105923. https://doi.org/10.1016/j.ijantimicag.2020.105937
- Rathi, S., Ish, P., Kalantri, A., & Kalantri, S. (2020). Hydroxychloroquine prophylaxis for COVID-19 contacts in India. The Lancet Infectious Diseases, 20(10), 1118-1119. https://doi.org/10.1016/S1473-3099(20)30313-3
- Rodriguez-Morales, A. J.,Bonilla-Aldana, D. K., Balbin-Ramon, G. J., Rabaan, A. A., Sah, R., Paniz-Mondolfi, A., & Esposito, S. (2020). History is repeating itself: Probable zoonotic spillover as the cause of the 2019 novel coronavirus epidemic. Infezioni in Medicina, 28(1), 3-5.
- Simpson, S., Kaufmann, M. C., Glozman, V., & Chakrabarti, A. (2020). Disease X: accelerating the development of medical countermeasures for the next pandemic. The Lancet Infectious Diseases, 20(5), e108-e115.
- Skipper, C. P., Pastick, K.A., Engen, N. W., Bangdiwala, A. S., Abassi, M., Lofgren, S. M., & Boulware, D. R. (2020). Hydroxychloroquine in nonhospitalized adults with early COVID-19: A randomized trial. Annals of Internal Medicine, 173(8), 623-631.
- Varshney, S. K., & Prasanna, N. K. (2021). Vaccine diplomacy: Exploring the benefits of international collaboration. Current Trends in Biotechnology and Pharmacy, 15(1), 110-114.
- Zhang, H., Li, X., Yu, H.,Zhang, Y., Li, M., Wang, H., Wang, D., Wang, H., Fu, Q., Liu, M., Ji, C., Ma, L., Tang, J., Li, S., Miao, J., Zheng, H., & Yi, H. (2019). Prognostic significance of perihematomal edema in acute intracerebral hemorrhage: Pooled analysis from the intensive blood pressure reduction in acute cerebral hemorrhage trial studies. Stroke, 46(4), 1009-1013. https://doi.org/10.1016/j.isci.2019.10.049